The Latest from Switzer

Buy, Hold, Sell, What the Brokers Say…(25 May 2026)
Switzer Report Subscriber Exclusive
Buy, Sell, Hold

Buy, Hold, Sell, What the Brokers Say…(25 May 2026)

For the week ending Friday 22 May 2026, FNArena recorded eight upgrades and nine downgrades from seven brokers monitored daily across ASX-listed companies.

Rudi Filapek-Vandyck 25 May
“HOT” stock: Betashares Global Energy ETF (FUEL)
Switzer Report Subscriber Exclusive
Investing

“HOT” stock: Betashares Global Energy ETF (FUEL)

In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why FUEL remains a buy and why he expects a very large…

Maureen Jordan 21 May
Buy, Hold, Sell, What the Brokers Say… (21 May 2026)
Switzer Report Subscriber Exclusive
Broker Recommendations

Buy, Hold, Sell, What the Brokers Say… (21 May 2026)

For the week ending Friday 15 May 2026, FNArena recorded three upgrades and seven downgrades from seven brokers monitored daily across ASX-listed companies.

Rudi Filapek-Vandyck 21 May
Do you play defence or offence?
Switzer Report Subscriber Exclusive
Investing

Do you play defence or offence?

Markets are at record highs, yet the world feels anything but settled. In this piece, I weigh up the case for staying fully invested versus…

Peter Switzer 18 May
What the 2026 Federal Budget means for your investments
Switzer Report Subscriber Exclusive
Investing

What the 2026 Federal Budget means for your investments

The 2026 Federal Budget landed three significant tax changes that every Australian investor needs to understand. Here’s a breakdown of what’s changing on capital gains…

Paul Rickard 18 May
‘HOT’ stock: Sigma Healthcare (SIG)
Switzer Report Subscriber Exclusive
Investing

‘HOT’ stock: Sigma Healthcare (SIG)

Raymond Chan, Private Client Adviser & Head of Asian Desk at Morgans highlights that Sigma Healthcare’s (SIG) year-to-date update shows continued strong momentum.

Maureen Jordan 18 May
Four more heart medicine stars
Switzer Report Subscriber Exclusive
Investing

Four more heart medicine stars

This week, I’m looking at the rest of the ASX-listed cardiac health cohort – all of which have different angles in heart health.

James Dunn 18 May